CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −378 | $578.07 | $219K | 18,916 |
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −40 | $578.76 | $23K | 18,876 |
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 42,500 | ||
| 2026-04-30 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $569.54 | $205K | 49,653 |
| 2026-04-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,194 | $570.76 | $681K | 48,459 |
| 2026-04-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,826 | $571.59 | $2.2M | 44,633 |
| 2026-04-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,640 | $572.57 | $939K | 42,993 |
| 2026-04-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −928 | $573.85 | $533K | 42,065 |
| 2026-04-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −312 | $574.79 | $179K | 41,753 |
| 2026-04-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −424 | $576.14 | $244K | 41,329 |
| 2026-04-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −316 | $577.10 | $182K | 41,013 |
| 2026-04-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −460 | $577.97 | $266K | 40,553 |
| 2026-04-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $579.51 | $23K | 40,513 |
| 2026-04-30 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 81,788 | ||
| 2026-04-29 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −8 | $565.27 | $5K | 50,005 |
| 2026-04-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −32 | $566.34 | $18K | 49,973 |
| 2026-04-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −135 | $567.72 | $77K | 49,838 |
| 2026-04-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −322 | $568.98 | $183K | 49,516 |
Page 114 of 121 · 2,404 trades